Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Lumbar puncture and cerebrospinal-fluid interpretation

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Suspected bacterial meningitis, encephalitis, subarachnoid haemorrhage, rapidly progressive neurological deficit or raised intracranial pressure requires immediate senior assessment. Never delay empirical antimicrobials or aciclovir solely to obtain CSF; defer puncture and image or stabilise first when there is shock, respiratory compromise, uncontrolled seizures, bleeding risk or clinical concern for mass effect.

Synopsis

Select, prepare and perform lumbar puncture safely, preserve diagnostic yield and interpret opening pressure and cerebrospinal-fluid results in relation to timing, serum measurements and clinical probability.

  • Define the question before puncture: infection, inflammation, subarachnoid haemorrhage, malignant infiltration, pressure disorder and therapeutic drainage require different timing, tubes, paired blood tests and laboratory handling.
  • Obtain consent covering purpose, alternatives, discomfort, bleeding, infection, post-dural-puncture headache, failure and the rare risk of neurological deterioration when contraindications are missed.
  • Check observations, conscious level, focal signs, optic discs where competent, anticoagulants, antiplatelets, platelet count and coagulation context, spinal anatomy, local infection and cardiorespiratory ability to tolerate positioning.
  • Brain imaging before LP is selective, not routine. Shock, airway compromise or strong mass-effect risk changes the order; imaging itself does not make puncture safe if clinical contraindications persist.
  • Use an aseptic technique and an atraumatic small-gauge needle when feasible. Position the patient laterally for a valid opening pressure, relaxed with legs no more flexed than needed after the interspace is entered.
  • Measure opening pressure at equilibrium with the manometer zeroed at the needle, recording position, sedation, straining and technical limitations. A number obtained seated is not interchangeable with standard lateral measurement.
  • Plan sample allocation before starting and label tubes in sequence. Typical studies include paired glucose, protein, cells and differential, Gram stain and culture, with PCR, cytology, oligoclonal bands or specialist tests added for the actual syndrome.
  • CSF glucose must be interpreted against a near-simultaneous blood glucose. A low CSF-to-blood relationship can support bacterial, tuberculous, fungal or malignant disease but is not exclusive to one cause.
  • Neutrophilic pleocytosis, high protein and low glucose suggests bacterial meningitis, yet early viral infection, partially treated disease and immunosuppression can produce atypical patterns; microbiology and clinical severity govern action.
  • For suspected aneurysmal subarachnoid haemorrhage after negative CT, follow NICE NG228: CT timing matters and, when LP is indicated, allow at least twelve hours from symptom onset before spectrophotometric bilirubin analysis.
  • A falling red-cell count across tubes does not reliably distinguish a traumatic tap from subarachnoid bleeding. Use bilirubin spectrophotometry, CT timing and the whole clinical pathway rather than visual inspection alone.
  • Communicate urgent samples directly to the laboratory, record antimicrobial timing and transport requirements, review every final culture and PCR result and arrange a plan for unresolved or incidental abnormalities.

Key red flags

Pyogenic bacterial pattern

Raised opening pressure, turbid fluid, neutrophilic pleocytosis, increased protein and reduced CSF glucose relative to blood supports bacterial meningitis, but prior antibiotics, early disease and immunosuppression can alter every component.

Viral meningoencephalitic pattern

Lymphocytic pleocytosis with moderately increased protein and usually preserved glucose supports viral infection. Early viral disease may be neutrophilic, and HSV encephalitis can have red cells, so PCR and phenotype are essential.

Tuberculous or fungal pattern

Raised pressure, lymphocytic cells, high protein and low glucose can suggest tuberculosis or fungal disease. Yield depends on volume, repeated sampling and specialist microbiology, and empirical decisions may precede confirmation.

Subarachnoid blood pattern

CSF bilirubin detected by validated spectrophotometry at the correct interval can support subarachnoid haemorrhage after appropriate CT assessment. Oxyhaemoglobin alone is vulnerable to artefact from traumatic sampling.

Raised opening-pressure syndrome

A reproducibly raised lateral opening pressure with an otherwise appropriate CSF profile can support intracranial hypertension, but obesity, Valsalva, pain, sedation, flexion and positioning can falsely elevate the reading.

Investigation priorities

01
Opening pressureFirst step

Measure subarachnoid pressure for suspected intracranial hypertension, infection and selected other syndromes.

Management branches

Suspected CNS infectionTreat before unsafe delay

Fever, headache, meningism, altered behaviour, reduced consciousness, focal deficit, rash or seizure creates concern for meningitis or encephalitis.

  1. Perform ABCDE, obtain blood cultures and other immediate samples and start guideline-concordant empirical antibiotics and, when indicated, aciclovir and adjunctive therapy without waiting for imaging or LP if delay would result.
  2. Assess cardiorespiratory stability, conscious level, focal signs, papilloedema risk, recent seizure and haemostasis to decide whether puncture can occur now or needs CT and specialist review first.
  3. Send planned CSF urgently with paired glucose, document pre-treatment timing and refine isolation, antimicrobial and public-health actions with microbiology, infection and national guidance.

Key medicines

Lidocaine 1% local anaestheticInfiltrate the skin and deeper tract incrementally after aspiration, using the smallest effective volume and remaining below the local maximum dose, commonly 3 mg/kg without adrenaline.Confirm allergy, avoid intravascular injection, calculate all lidocaine exposure and monitor for neurological or cardiovascular toxicity; an effective skin wheal alone may not anaesthetise the deeper periosteal tissues.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG240 bacterial meningitis recommendationsCurrent national recognition, treatment timing, imaging and lumbar-puncture guidance for bacterial meningitis.
  • NICE NG228 subarachnoid haemorrhage recommendationsCT timing, indications for LP and twelve-hour bilirubin-sampling guidance.
  • British Infection Association published guidelinesUK specialist infection guidance and source documents relevant to adult CNS infection management.
  • UKHSA meningococcal disease public-health guidanceNational laboratory, notification and contact-management framework after suspected meningococcal disease.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom